JP Morgan Chase
KMTS

JP Morgan Chase’s Kestra Medical Technologies KMTS Stock Holding History

JP Morgan Chase’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473K Buy
25,786
+5,997
+30% +$141K ﹤0.01% 5075
2025
Q4 		$525K Buy
19,789
+5,364
+37% +$138K ﹤0.01% 4987
2025
Q3 		$343K Sell
14,425
-1,044
-7% -$18.7K ﹤0.01% 5239
2025
Q2 		$256K Buy
+15,469
New +$338K ﹤0.01% 5117

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase's KMTS Position: Q1 2026 in Review

JP Morgan Chase increased its Kestra Medical Technologies (KMTS) stake by 30% in Q1 2026, buying an estimated $141K and bringing the position to 25,786 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #5075.

JP Morgan Chase first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $525K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • JP Morgan Chase held 25,786 shares of Kestra Medical Technologies worth $473K as of Q1 2026.
  • JP Morgan Chase bought 5,997 Kestra Medical Technologies shares in Q1 2026, an estimated $141K.
  • Kestra Medical Technologies made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5075 holding.
  • JP Morgan Chase first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • JP Morgan Chase's Kestra Medical Technologies position peaked at $525K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.